All News

The appellate ruling flatly rejected the request to overturn regulators' approval of Horizon's tiered network. But this is not the end of litigation over the controversial plan.

Can the Oncotype DX Breast Cancer Assay impact recommendation and receipt of chemotherapy in early stage breast cancer? Does the test also improve patient experience? These were some of the questions asked by researchers at the University of Michigan, and the results presented during the annual meeting of the American Society of Clinical Oncology.

Older patients and those with other complications are at greatest risk.

There is a significant variation in quality of urgent healthcare provided during virtual visits, according to a new study published in JAMA Internal Medicine.

What we're reading, June 7, 2016: opioid restrictions disproportionately affect older patients with chronic pain; Genentech and OSI Pharmaceuticals settle Tarceva lawsuit; and trouble raising Zika virus funds.

The American Society of Clinical Oncology’s first-ever clinical trial is growing with the addition of its seventh and eighth pharmaceutical companies, Bayer and Merck, and 30 additional trial participants.

After reading two CDC accounts of this strange set of symptoms among gay men, Anthony S. Fauci, MD, recalls redirecting his research efforts to combat a disease that didn't even have a name.

The first study sheds light on the complex interaction between underlying metabolic risk and breast cancer.

What we're reading, June 6, 2016: Vice President Joe Biden will announce the launch of an open-access cancer research database, and a new bill in Congress would allow companies to repurpose existing drugs for rare diseases.

A secondary analysis of data from the TECOS trial of sitagliptin finds that the drug does not affect the risk for heart failure hospitalization or related adverse clinical outcomes in people with type 2 diabetes

An analysis by Avalere Health of Hillary Clinton’s proposal to allow Americans age 50 and over to Medicare estimates that 13 million adults who are uninsured or have individual coverage through the private market could be eligible for such a program.

The top managed care stories this week included an update to the American Society of Clinical Oncology's value framework, a study that reported readmission rates among safety net hospitals after cancer surgery, and findings that bariatric surgery can benefit patients with diabetes.

Cardiovascular outcomes trials, new technologies, and the fight over what we eat will be featured at the upcoming 76th Scientific Sessions of the American Diabetes Association in New Orleans.

Donald B. Verrilli won key cases to keep intact the Affordable Care Act. With his winning argument in the 2015 case to extend marriage equality to all states, same-sex couples could no longer be denied the right to cover a spouse on an insurance policy or be named next-of-kin for medical decisions.

Recent coverage of our research, in both the healthcare and mainstream press.

A study presented at the ongoing European Obesity Summit has confirmed a correlation between the risk of developing high grade prostate cancer and high body mass index and waist circumference.

What we're reading, June 3, 2016: Florida's crackdown on opioid prescriptions is working; some California physicians are uneasy about prescribing lethal doses to terminally ill patients; and Ashish Jha, MD, MPH, shines a spotlight on the real culprit of preventable medical errors.

The 57-year-old music icon officially became the most high-profile victim of the nation's opioid epidemic.

Interim results from the ongoing CANVAS (Canagliflozin Cardiovascular Assessment Study) clinical trial have found an increased risk of leg and foot amputations associated with the popular diabetes medication.

People who live in the country’s 2 biggest states that have not expanded Medicaid have more complaints about healthcare costs and quality and would like their states to expand the program.

Cigna and Anthem, which are potentially merging in the future, both announced they were taking steps to curb inappropriate opioid and prescription drug use.

The FDA has approved the first ever blood-based companion diagnostic test. The cobas EGFR Mutation Test v2 was developed by Roche for the drug erlotinib (Tarceva), which was developed by Astellas for the treatment of non-small cell lung cancer.

What we're reading, June 2, 2016: Medicaid can cover mosquito repellent to prevent the spread of the Zika virus; Karen DeSalvo, MD, MPH, MSc, discusses New Orleans post-Katrina, life expectancy, and more; and teen births hit an all-time low.

Survival rates of patients with liver disease were better among those with 2 or more visits to a gastroenterologist, but access issues impede patients from receiving care.

The acquisition lets Myriad acquire the maker of EndoPredict, which just received reimbursement status from Aetna and meets ASCO guidelines for payment by Medicare contractors.

The proposal calls for 2-year and 10-year goals to gradually reduce Americans' salt intake. This strategy has been used in the past when it became clear that FDA would seek ways to limit sugar consumption.

Hospitals that serve the more vulnerable population perform worse with their readmission rate following cancer surgery, and the subsequent penalties that they face can further strain the hospital’s already burdened finances.

Historically, men and women who are currently serving or who have previously served in the United States military have limited treatment options when it comes to infertility resulting from service-related injury.

What we're reading, June 1, 2016: for the first time in a decade, the death rate in the United States has risen; UnitedHealth confirms it will leave the California insurance exchange in 2017; and just 6% of Americans do the 5 things they need to prevent disease.

During the Pharmacy Quality Alliance's Annual Meeting, 2 speakers discussed opioid abuse and how to combat the growing epidemic through the use of a prescription monitoring program.